Avantra said that TD2's pharma clients could use its platform to identify appropriate biomarkers for use with drugs in development.
Avantra Biosciences' Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay, Akonni Biosystems' TruSentry System, Agilent Technologies' BenchBot Robot, Exiqon's Mircury LNA microRNA Labeling Kits
Avantra was founded last year by Courtagen Capital Group to commercialize the assets of Decision Biomarkers, a protein biomarker technology firm that shuttered its business and filed for Chapter 7 bankruptcy in December 2009.
Formed from what had been Decision Biomarkers, Avantra is eyeing a launch of its biomarker detection platform in early 2011.
The company is being launched by Courtagen Capital Group using assets from defunct biotech firm Decision Biomarkers, which Courtagen purchased in bankruptcy court last December.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.